Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
88.1M
-
Shares change
-
-18M
-
Total reported value, excl. options
-
$27.4M
-
Value change
-
-$7.46M
-
Put/Call ratio
-
1.22
-
Number of buys
-
29
-
Number of sells
-
-57
-
Price
-
$0.31
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q2 2025
108 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q2 2025.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.1M shares
of 144M outstanding shares and own 61.3% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (18.7M shares), Vestal Point Capital, LP (11.5M shares), Propel Bio Management, LLC (11.3M shares), Knoll Capital Management, LLC (7.8M shares), BlackRock, Inc. (5.22M shares), VANGUARD GROUP INC (4.73M shares), Simplify Asset Management Inc. (4.49M shares), Pathstone Holdings, LLC (2.64M shares), TANG CAPITAL MANAGEMENT LLC (2.43M shares), and Rock Springs Capital Management LP (2.08M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.